Therefore, the double-labelling of cells using Kit and Ano1, when coupled with cell morphology, is thought to be a more reliable diagnostic approach for all ICC types in the GI tract of mice and humans than use of any single marker, and this approach is fast becoming the standard for ICC immunohistological identification [66]. The gene discussed is ANO1; the disease is intrahepatic cholangiocarcinoma.